CN Patent

CN102146059A — 喹唑啉衍生物、制备方法及其应用

Assigned to Shanghai Allist Pharmaceuticals Inc · Expires 2011-08-10 · 15y expired

What this patent protects

本发明公开了一种作为酪氨酸激酶不可逆抑制剂的喹唑啉衍生物，以及这类衍生物作为人类表皮生长因子受体(EGFR)突变体T790M的抑制剂和抗癌剂的应用。本发明还涉及其制备方法，以及一种包含喹唑啉衍生物的药物组合物。

USPTO Abstract

本发明公开了一种作为酪氨酸激酶不可逆抑制剂的喹唑啉衍生物，以及这类衍生物作为人类表皮生长因子受体(EGFR)突变体T790M的抑制剂和抗癌剂的应用。本发明还涉及其制备方法，以及一种包含喹唑啉衍生物的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN102146059A
Jurisdiction
CN
Classification
—
Expires
2011-08-10
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Allist Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.